Given the properties of CNTF, particularly its role as a promyelinating neurotrophic factor, numerous clinical trials in the late 1990s and early 2000s aimed to evaluate its efficacy in relation to ALS [271]. This evidence concerns the gene CNTF and amyotrophic lateral sclerosis.